Advertisement
Advertisement
U.S. markets close in 1 hour 31 minutes
Advertisement
Advertisement
Advertisement
Advertisement

EV Biologics, Inc. (YECO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.60260.0000 (0.00%)
As of 03:15PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6026
Open0.6026
BidN/A x N/A
AskN/A x N/A
Day's Range0.6026 - 0.6026
52 Week Range0.5100 - 5.8300
Volume21
Avg. Volume165
Market Cap40.626M
Beta (5Y Monthly)-1.74
PE Ratio (TTM)N/A
EPS (TTM)-0.2290
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est32.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for YECO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • YULONG ECO-MATERIALS LIMITED
    Daily – Vickers Top Buyers & Sellers for 09/29/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    8 months agoArgus Research
View more
  • ACCESSWIRE

    EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line Development

    TAMPA, FL / ACCESSWIRE / April 12, 2022 / EV Biologics Corp, OTC PINK:YECO, today announced that it has succeeded in isolating primary progenitor cells from tissue using a xeno-free process.The Company has been developing an improved process for isolation of progenitor cells from tissue to generate cell banks for therapeutic nanoparticle production and further cell line development.

  • ACCESSWIRE

    EV Biologics Updates on FINRA Filings

    NASHVILLE, TN / ACCESSWIRE / March 9, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with the latest information about its submitted FINRA applications for name change and NFT dividend distribution.The Company announced on August 6, 2020, that it had submitted its name change filing with FINRA.

  • ACCESSWIRE

    EV Biologics Updates on FINRA

    NASHVILLE, TN / ACCESSWIRE / January 18, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its submitted FINRA applications for name change and NFT dividend distribution.The Company is still awaiting approval from FINRA for the NFT dividend distribution.

Advertisement
Advertisement